Dr Matt Rowland is a Senior Clinical Lecturer in Intensive Care Medicine at the University of Oxford. He graduated in 2003 from the Royal Free and University College London Medical School with distinction and gained FRCA and FFICM whilst completing specialist intensive care training in the Oxford Deanery.

In 2011, he was awarded a Clinical Research Training Fellowship in 2011 by the Medical Research Council to undertake a DPhil investigating early brain injury in subarachnoid haemorrhage which he completed in 2015.

He has published a number of first author papers on subarachnoid haemorrhage and his main research interest is early brain injury in critically unwell patients. He holds a number of grants for studies investigating mechanisms of early brain injury as chief investigator as well as being principle investigator on a the SOS Trial – a NIHR UK randomised controlled trial of osmotherapy in patients with severe traumatic brain injury. 

In 2020, he was awarded a one year senior clinical/industry fellowship to work at Roche in the Pharma Development Neurosciences division. Academically, he is supervising ongoing studies investigating acute severe traumatic brain injury, therapeutic options for subarachnoid haemorrhage and neurological outcomes after cardiac arrest.